Recombinant Human Chorionic Gonadotropin in Preventing Breast Cancer in Premenopausal Women With BRCA1 Mutations
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: BRCA1 Mutation|Breast Cancer
Interventions: BIOLOGICAL: recombinant human chorionic gonadotropin|GENETIC: microarray analysis|OTHER: immunohistochemistry staining method|OTHER: laboratory biomarker analysis|PROCEDURE: needle biopsy
Sponsor: Fox Chase Cancer Center
Collaborators: National Cancer Institute (NCI)